VYGR stock forecast
Our latest prediction for Voyager Therapeutics Inc's stock price was made on the Feb. 28, 2023 when the stock price was at 7.18$.
In the short term (2weeks), VYGR's stock price should underperform the market by -0.25%. During that period the price should oscillate between -9.09% and +7.21%.
In the medium term (3months), VYGR's stock price should underperform the market by -7.38%. During that period the price should oscillate between -24.06% and +19.61%.
Get email alertsCreate a solid portfolio with VYGR
About Voyager Therapeutics Inc
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager's wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases.
At the moment the company generates 130M USD in revenues.
On its last earning announcement, the company reported a loss of -1.27$ per share.
The book value per share is 2.52$
Three months stock forecastFeb. 28, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130M | 53.93% | -20M | -15.73% | -1M | -1.27 | - | - | 38M | 2.52 | - | - | - |